Literature DB >> 25481647

Interferons as components of the complex web of reactions sustaining inflammation in idiopathic inflammatory myopathies.

Boel De Paepe1.   

Abstract

Evidence accumulates implicating interferons (IFNs) in the chronic inflammation associated with the idiopathic inflammatory mypathies (IM). Dermatomyositis in particular appears to display a strong IFN type 1 signature. Proposed pathogenic actions of IFNs include the upregulation of major histocompatibility complex class I on muscle fibres, and the induction of a plethora of pro-inflammatory factors, including cytokines and chemokines. This review brings together findings on IFNs and IFN-induced factors, sketching their roles in IM immunopathogenesis in general and dermatomyositis in particular, and offering a basis for exploring their potential therapeutic relevance.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemokines; Cytokines; Inflammatory myopathy; Interferon-inducible genes; Interferons

Mesh:

Substances:

Year:  2014        PMID: 25481647     DOI: 10.1016/j.cyto.2014.10.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

Review 1.  Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies.

Authors:  Boel De Paepe; Jana Zschüntzsch
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

2.  Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.

Authors:  Josefine Radke; Randi Koll; Corinna Preuße; Debora Pehl; Kremena Todorova; Constanze Schönemann; Yves Allenbach; Eleonora Aronica; Marianne de Visser; Frank L Heppner; Joachim Weis; Soroush Doostkam; Thierry Maisonobe; Olivier Benveniste; Hans-Hilmar Goebel; Werner Stenzel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-06

3.  Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies.

Authors:  Travis B Kinder; Christopher R Heier; Christopher B Tully; Jack H Van der Muelen; Eric P Hoffman; Kanneboyina Nagaraju; Alyson A Fiorillo
Journal:  Arthritis Rheumatol       Date:  2020-05-31       Impact factor: 10.995

4.  Distinct interferon signatures stratify inflammatory and dysimmune myopathies.

Authors:  Muriel Rigolet; Cyrielle Hou; Yasmine Baba Amer; Jessie Aouizerate; Baptiste Periou; Romain K Gherardi; Peggy Lafuste; François Jérôme Authier
Journal:  RMD Open       Date:  2019-02-26

5.  Activation of cGAS-STING pathway - A possible cause of myofiber atrophy/necrosis in dermatomyositis and immune-mediated necrotizing myopathy.

Authors:  Meichen Zhou; Xiaoxiao Cheng; Wenhua Zhu; Jianhua Jiang; Sijia Zhu; Xuan Wu; Meirong Liu; Qi Fang
Journal:  J Clin Lab Anal       Date:  2022-08-28       Impact factor: 3.124

6.  Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.

Authors:  Joan Raouf; Helena Idborg; Petter Englund; Helene Alexanderson; Maryam Dastmalchi; Per-Johan Jakobsson; Ingrid E Lundberg; Marina Korotkova
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

7.  Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.

Authors:  S Soponkanaporn; C T Deakin; P W Schutz; L R Marshall; S A Yasin; C M Johnson; E Sag; S L Tansley; N J McHugh; L R Wedderburn; T S Jacques
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-04       Impact factor: 8.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.